Acute Respiratory Distress SyndromeARISENCT07025421
The ARISE Study - Use of Vertical Positioning
A study testing Intervention Upright Bed positioning in people with Acute Respiratory Distress Syndrome, run by University of Alabama at Birmingham at 1 site in United States.
Trial summary
The pilot study will randomize 40 ARDS patients who if proning were required would be randomized to upright bed positioning or to stand of care with bed in the head of bed elevation position Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Acute Respiratory Distress Syndrome
- What is being tested?
- Intervention Upright Bed positioning
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 25 Aug 2025to 31 Aug 2028
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Acute Respiratory Distress Syndrome
Who cannot join
- Cancer
- Active tracheostomy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Alabama at Birmingham
Birmingham, Alabama, 35223
About this study
Official title: The Arise Study - Use of Vertical Positioning
The pilot study will randomize 40 ARDS patients who if proning were required would be randomized to upright bed positioning or to stand of care with bed in the head of bed elevation position
Read the detailed description
Patients will be randomized to receive either daily upright bed positioning or to receive standard of care with head of bed elevated.
- Conditions
- Acute Respiratory Distress Syndrome
- Being tested
- Intervention Upright Bed positioning
- Keywords
- Bed Position
- Medical subject headings
- Respiratory Distress Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intervention Upright Bed positioningOther
Patient in receipt of the upright bed positioning will receive daily upright bed positioning time each day of mechanical ventilation following the time required by institutional protocol for ARDS - associated prone positioning
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Active comparator | Upright bed positioning Receives: Other: Intervention Upright Bed positioning |
| Standard of Care | No intervention | Standard of Care Head of Bed Elevation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Tidal Volume
Mechanical Ventilator Tidal Volume
Measured: within first 7 days of mechanical ventilation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jun 2025
- Study start25 Aug 2025
- Primary completion30 Jun 2028 (estimated)
- Study completion31 Aug 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Respiratory Distress SyndromeStudies of the same condition, open and under way.
- More trials run by University of Alabama at BirminghamThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Peter Morris, University of Alabama at Birmingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07025421
- Sponsor's protocol ID
- IRB-300014712
- Other IDs
- UAB
- Acronym
- ARISE
- Status last verified
- Aug 2026
- First submitted
- 9 Jun 2025
- Last updated
- 27 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Review with the UAB IRB for each request